|
Orchid Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
3963.70 Cr.
|
P/BV
|
3.11
|
Book Value (Rs.)
|
251.16
|
|
52 Week High/Low (Rs.)
|
1984/604
|
FV/ML
|
10/1
|
P/E(X)
|
39.78
|
|
Bookclosure
|
09/08/2023
|
EPS (Rs.)
|
19.65
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 921.93 | 816.11 | 656.66 | 556.85 | 449.60 |
| Other Operating Revenues | 0.00 | 3.25 | 9.24 | 2.71 | 0.46 |
| Total Operating Revenues | 921.93 | 819.37 | 665.90 | 559.56 | 450.06 |
| | | | | | |
| Other Income | 27.47 | 30.86 | 19.43 | 9.00 | 15.23 |
| Total Revenue | 949.40 | 850.23 | 685.33 | 568.56 | 465.29 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 585.46 | 528.35 | 406.10 | 340.62 | 245.60 |
| Purchase Of Stock-In Trade | 2.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -43.85 | -43.89 | -21.48 | -27.06 | -17.09 |
| Employee Benefit Expenses | 86.36 | 69.64 | 65.35 | 63.28 | 67.11 |
| Finance Costs | 14.54 | 16.35 | 32.23 | 32.01 | 51.34 |
| Depreciation And Amortisation Expenses | 34.55 | 33.24 | 54.79 | 87.02 | 108.92 |
| Other Expenses | 174.17 | 154.59 | 132.31 | 129.59 | 104.67 |
| Total Expenses | 853.84 | 758.29 | 669.29 | 625.46 | 560.54 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 95.56 | 91.95 | 16.04 | -56.90 | -95.25 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 39.21 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 95.56 | 91.95 | 55.25 | -56.90 | -95.25 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.10 | -3.23 | 0.00 | 0.00 | 0.00 |
| Tax For Earlier Years | -0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | -0.19 | -3.12 | 0.00 | 0.00 | 0.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 95.76 | 95.06 | 55.25 | -56.90 | -95.25 |
| | | | | | |
| Profit/Loss From Continuing Operations | 95.76 | 95.06 | 55.25 | -56.90 | -95.25 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | -6.78 | 58.47 | -21.28 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | -6.78 | 58.47 | -21.28 |
| Profit/Loss For The Period | 95.76 | 95.06 | 48.47 | 1.57 | -116.53 |
| Share Of Profit/Loss Of Associates | 3.90 | -2.90 | -2.15 | -3.52 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 99.66 | 92.17 | 46.32 | -1.95 | -116.53 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 19.65 | 19.06 | 11.35 | -0.48 | -28.55 |
| Diluted EPS (Rs.) | 19.65 | 19.06 | 11.35 | -0.48 | -28.55 |
